Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
22m
BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce ...
22m
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: QLGN) (the “Company”) today announced that on September 11, ...
39m
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Secret Service probing post
Body found in SUV
FCC chair denies Trump call
Cancels appearance w/ Duda
Boy kills bear, saves father
Ban called for in TX schools
Families lose appeal
To get a second moon
NYC subway joyride arrest
Man charged for threats
Hold campaign event in MI
Collapse hazard recall
Vows to remain in race
PGA welcomes LIV players
To visit US next week
Retires after 17 seasons
FTC on privacy controls
160M euros to Ukraine
Brazil threatens daily fines
Gun case sentencing delay
Hails economic progress
Existing home sales drop
Dow, S&P hit record highs
EU warns Apple
COVID, Wuhan market link
UN backs Palestine
Israel strikes Hezbollah
Overdose deaths drop in US
To receive Holbrooke award
Makes MLB history
Feedback